AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Insight Molecular Diagnostics Inc. Director's Dealing 2015

Dec 30, 2015

34238_dirs_2015-12-30_2e84cc13-474f-496d-aba0-010ba24f39cc.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2015-12-30

Reporting Person: KARFUNKEL GEORGE (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value	3659860	Direct